KBI Biopharma: How to stand out in the CMO space




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: KBI Biopharma: How to stand out in the CMO space
Released on: June 23, 2016. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    KBI Biopharma is a CMO focused exclusively on biologics.
  • Summary
  • Transcript
  • Participants
  • Company
KBI Biopharma is a CMO focused exclusively on biologics. Bernardo Estupinan-Gaisbauer, Vice President – Business Development at KBI Biopharma, discusses their strategy for partnering, and the challenges of staying competitive in the CMO sector.
KBI Biopharma is a CMO focused exclusively on biologics. Bernardo Estupinan-Gaisbauer, Vice President – Business Development at KBI Biopharma, discusses their strategy for partnering, and the challenges of staying competitive in the CMO sector.
Bernardo Estupinan-Gaisbauer
KBI Biopharma
ASK KBI We are a biopharma contract development & manufacturing organization driven to improve the quality of human life – we do this by serving our clients in the accelerated development of their needed medicines. To date, we’ve served over 200 clients around the world. We help our client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services in an agile, client-friendly partnering environment. Clients include global pharmaceutical and biotechnology companies and academic/non-profit organizations. Today we serve more than 200 clients in the US, Canada, Europe, Korea and Japan, including most of the top ten pharmaceutical companies. KBI was founded in 1996 and is based in Durham, North Carolina, near Research Triangle Park (RTP). KBI’s extensive track record of successful process development and manufacturing programs is a result of our unique approach of applying the insight gained from our biophysical and biochemical protein characterization methodologies, towards the development of robust and scalable processes. KBI delivers expert and integrated process development and cGMP manufacturing of recombinant protein Active Pharmaceutical Ingredients (API) for our clients. KBI’s scientific, quality and regulatory staff offers extensive experience – proven through numerous IND and NDA submissions – to meet the challenges that arise at all stages of drug development.